We’re excited to announce that Berkeley Lights and IsoPlexis are moving forward together as PhenomeX, a premier functional cell biology company. Visit Site

ARTICLE: Broadly neutralizing antibodies target the coronavirus fusion peptide

News 04.10.22

The Pandemic Is Driving Innovative Microfluidic Disease Detection

News 08.11.21

Berkeley Lights and Bayer Announce Agreement to Spur Discovery of Next-Generation Traits

News 08.05.21

Mapping the Future of Cell Culture and Cell Line Development

News 05.25.21

Meet The Collaboration Solving Some Of Antibody Discovery’s Toughest Problems

News 05.11.21

Leveraging optofluidics to make therapeutic antibody discovery easier

News 04.15.21

Researchers pivot from COVID-19 response to preventing future pandemics

News 04.12.21

Military programs aiming to end pandemics forever

News 03.05.21

From Discovery To Delivery: Addressing Challenges in Cell Therapy

News 03.04.21

Biotech’s Brave New World: Bay Area startups band together to ramp up coronavirus research and testing

News 01.13.21

JP Morgan Healthcare Conference 2021, Day Two:Qiagen, Invitae, Agilent, Sema4, More

News 11.05.20

Finding the Best Cell for the Job

News 11.01.20

Pinpointing Bioprocess Development Success

News 10.21.20

Big Tech Is Under Pressure. Here’s Where to Find Growth

News 10.05.20

Berkeley Lights Helps Researchers Connect Genomic, Functional Characteristics of Cells

News 10.01.20

Soaring Biomedical IPOs Raise Questions About Money Left on the Table

News 09.22.20

Berkeley Lights Will Receive IPO of the Year Award at SynBioBeta 2020

News 09.14.20

Optofluidics Technology Accelerates Discovery of COVID-19 Treatments